| Primary |
| Hiv Infection |
70.8% |
| Drug Use For Unknown Indication |
8.5% |
| Product Used For Unknown Indication |
3.3% |
| Asthma |
2.2% |
| Hiv Infection Cdc Category B2 |
1.8% |
| Prophylaxis |
1.5% |
| Dyslipidaemia |
1.1% |
| Glaucoma |
1.1% |
| Hiv Infection Cdc Category C2 |
1.1% |
| Hypertension |
1.1% |
| Pain |
1.1% |
| Acquired Immunodeficiency Syndrome |
0.7% |
| Antiretroviral Therapy |
0.7% |
| Blood Cholesterol Increased |
0.7% |
| Helicobacter Gastritis |
0.7% |
| Hiv Infection Cdc Category A1 |
0.7% |
| Hiv Infection Cdc Category A2 |
0.7% |
| Immunosuppression |
0.7% |
| Liver Disorder |
0.7% |
| Anaemia |
0.4% |
|
| Myocardial Infarction |
20.4% |
| Cerebrovascular Accident |
7.4% |
| Thalamic Infarction |
7.4% |
| Pyrexia |
5.6% |
| Sudden Death |
5.6% |
| Viral Infection |
5.6% |
| Angioedema |
3.7% |
| Colour Blindness |
3.7% |
| Death |
3.7% |
| Dyspnoea |
3.7% |
| Fatigue |
3.7% |
| Oedema Peripheral |
3.7% |
| Proteinuria |
3.7% |
| Rash Pruritic |
3.7% |
| Toxoplasmosis |
3.7% |
| Viral Load Increased |
3.7% |
| Vomiting |
3.7% |
| Weight Increased |
3.7% |
| Abnormal Behaviour |
1.9% |
| Anaemia Haemolytic Autoimmune |
1.9% |
|
| Secondary |
| Hiv Infection |
49.7% |
| Drug Use For Unknown Indication |
12.4% |
| Drug Exposure During Pregnancy |
12.3% |
| Product Used For Unknown Indication |
7.1% |
| Schizophrenia |
2.1% |
| Antifungal Prophylaxis |
2.0% |
| Antiretroviral Therapy |
2.0% |
| Cytomegalovirus Chorioretinitis |
1.4% |
| Opportunistic Infection Prophylaxis |
1.4% |
| Insomnia |
1.3% |
| Prophylaxis |
1.3% |
| Maternal Exposure Timing Unspecified |
1.0% |
| Acquired Immunodeficiency Syndrome |
0.9% |
| Diabetes Mellitus |
0.9% |
| Burkitt's Lymphoma |
0.8% |
| Depressed Mood |
0.7% |
| Encephalitis Cytomegalovirus |
0.7% |
| Hiv Test Positive |
0.7% |
| Nephropathy |
0.7% |
| Pulmonary Tuberculosis |
0.7% |
|
| Drug Exposure During Pregnancy |
8.9% |
| Viral Load Increased |
8.9% |
| Polyarthritis |
7.8% |
| Renal Failure |
6.7% |
| Subarachnoid Haemorrhage |
6.7% |
| Pneumothorax |
5.6% |
| Pruritus |
5.6% |
| Skin Depigmentation |
5.6% |
| Abortion Spontaneous |
4.4% |
| Nephrolithiasis |
4.4% |
| Prostate Cancer |
4.4% |
| Vomiting |
4.4% |
| Diabetes Mellitus |
3.3% |
| Osteonecrosis |
3.3% |
| Patent Ductus Arteriosus |
3.3% |
| Placenta Praevia |
3.3% |
| Pneumonia |
3.3% |
| Trisomy 21 |
3.3% |
| Vitamin B12 Deficiency |
3.3% |
| White Blood Cell Count Decreased |
3.3% |
|
| Concomitant |
| Hiv Infection |
51.0% |
| Drug Use For Unknown Indication |
24.7% |
| Product Used For Unknown Indication |
7.5% |
| Prophylaxis |
2.4% |
| Hepatitis C |
1.9% |
| Mycobacterium Avium Complex Infection |
1.7% |
| Antifungal Prophylaxis |
1.5% |
| Acquired Immunodeficiency Syndrome |
1.1% |
| Drug Exposure During Pregnancy |
1.1% |
| Opportunistic Infection Prophylaxis |
1.1% |
| Hypertension |
1.0% |
| Cytomegalovirus Infection |
0.7% |
| Drug Eruption |
0.7% |
| Fungal Infection |
0.7% |
| Encephalitis Cytomegalovirus |
0.5% |
| Pain |
0.5% |
| Burkitt's Lymphoma |
0.5% |
| Diarrhoea |
0.5% |
| Pneumocystis Jiroveci Pneumonia |
0.5% |
| Alcoholic Liver Disease |
0.4% |
|
| Weight Decreased |
12.8% |
| Uveitis |
10.5% |
| Peripheral Vascular Disorder |
8.1% |
| Vomiting |
8.1% |
| Hodgkin's Disease |
5.8% |
| Mycobacterium Avium Complex Infection |
5.8% |
| Abortion Induced |
4.7% |
| Phlebitis |
4.7% |
| Pyrexia |
4.7% |
| Bronchopneumonia |
3.5% |
| Lymphoma |
3.5% |
| Nausea |
3.5% |
| Pain |
3.5% |
| Pancreatitis Acute |
3.5% |
| Pneumonia Pneumococcal |
3.5% |
| Poor Quality Sleep |
3.5% |
| Renal Tubular Disorder |
3.5% |
| Anogenital Warts |
2.3% |
| Anorectal Operation |
2.3% |
| Blood Triglycerides Increased |
2.3% |
|
